{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016374","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.174601+00:00","generated_at":"2026-05-18T19:09:59.058412+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nasdaq panel approves Dare Bioscience's compliance plan; deadline Aug 12, 2025","bullets":["Panel approved modified plan to regain compliance with Nasdaq Listing Rules 5550(b)(1) (≥$2.5M equity) or 5550(b)(2) (≥$35M MVLS).","Must demonstrate compliance by July 31, 2025; conditional listing ends August 12, 2025.","If plan fails, Nasdaq may delist common stock before August 12, 2025.","Company has been non-compliant with Rule 5550(b) since August 2024.","No assurances given that compliance will be achieved by the deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016374","json":"https://secwatch.observer/filing/0001641172-25-016374.json","markdown":"https://secwatch.observer/filing/0001641172-25-016374.md","text":"https://secwatch.observer/filing/0001641172-25-016374.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225016374/0001641172-25-016374-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000164117225016374/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T19:09:59.058412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}